Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antimetabolites, Antineoplastic”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Testing effectiveness (Phase 2)Ended earlyNCT00838578
What this trial is testing

Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Kyowa Kirin Co., Ltd. 65
Early research (Phase 1)Study completedNCT00001449
What this trial is testing

A Phase I Study of Weekly Gemcitabine in Combination With Infusional Fluorodeoxyuridine and Oral Calcium Leucovorin in Adult Cancer Patients

Who this might be right for
Neoplasms
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT00593151
What this trial is testing

Study of Safety, Tolerability, and Anti-Viral Effect of Locteron Compared to PEG-Intron in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Biolex Therapeutics, Inc. 32
Large-scale testing (Phase 3)Study completedNCT01964430
What this trial is testing

Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)

Who this might be right for
Pancreatic NeoplasmsDigestive System NeoplasmsNeoplasms by Site+7 more
Celgene 866
Post-approval studies (Phase 4)Study completedNCT01201811
What this trial is testing

Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic Syndromes
Celgene 44
Not applicableStudy completedNCT04736472
What this trial is testing

Implementing Pharmacogenetic Testing in Gastrointestinal Cancers

Who this might be right for
Gastrointestinal Cancer
Abramson Cancer Center at Penn Medicine 552
Testing effectiveness (Phase 2)UnknownNCT04962958
What this trial is testing

Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery

Who this might be right for
CarcinomaCarcinoma, HepatocellularLiver Neoplasms+6 more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 30
Testing effectiveness (Phase 2)Study completedNCT01397305
What this trial is testing

An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer

Who this might be right for
Rectal Cancer
Isofol Medical AB 24
Early research (Phase 1)Ended earlyNCT04310592
What this trial is testing

Natural Killer Cell (CYNK-001) Infusions in Adults with AML

Who this might be right for
LeukemiaLeukemia, MyeloidLeukemia, Myeloid, Acute+17 more
Celularity Incorporated 27
Large-scale testing (Phase 3)UnknownNCT01917279
What this trial is testing

Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBC

Who this might be right for
Breast NeoplasmsNeoplasms by SiteNeoplasm Metastasis+2 more
Binghe Xu 280
Early research (Phase 1)Study completedNCT02171221
What this trial is testing

Phase I Study of Oral DFP-11207 in Solid Tumors

Who this might be right for
Solid TumorsCancer
Delta-Fly Pharma, Inc. 23
Testing effectiveness (Phase 2)UnknownNCT04365101
What this trial is testing

Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19

Who this might be right for
CoronavirusCoronavirus InfectionSevere Acute Respiratory Syndrome Coronavirus 2+17 more
Celularity Incorporated 86